CSL investors see limited direct impact from U.S. pricing deals
UBS analysts cited by market talk say CSL’s U.S. pricing agreements—giving Medicaid access at comparable prices—are unlikely to have much direct financial impact.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.